4.6 Article

Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel

Journal

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 36, Issue 2-3, Pages 219-225

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2008.09.002

Keywords

Dermal microdialysis; Human subjects; Ketoprofen; Topical gel formulations; Bioavailability; Bioequivalence; Skin penetration

Funding

  1. Rhodes University Andrew Mellon Foundation (RT-A)
  2. National Research Foundation (IK), South Africa

Ask authors/readers for more resources

The purpose was to investigate dermal microdialysis (DMD) for the assessment of the bioavailability of a ketoprofen topical gel formulation and to evaluate this technique as a tool for the determination of bioequivalence. Four microdialysis probes were inserted into the dermis on the volar aspect of the forearms of 18 human subjects and the probes were perfused with normal saline for 60 min. A ketoprofen (2.5%, m/m) gel formulation (50 mg) was applied to the skin directly overlying the probes and samples were collected at 30 min intervals for 5 h. with the probes still in place in the dermis each site was scanned by ultrasound to determine the implantation depth of these probes. Ketoprofen concentration in dialysates was determined by LC-MS/MS. The area under the curve obtained from the concentration-time profiles from pairs of application sites in each subject was evaluated in order to assess bioequivalence. Ninety percent confidence intervals were calculated using the two one-sided test procedure and limits of 80-125% based on log-transformed data were used as acceptance criteria to declare bioequivalence. The intra-subject variability was 10% between probes whereas inter-subject variability was 68% (n = 18). Bioequivalence was confirmed with a power greater than 90%. (c) 2008 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

The Lidose Hard Capsule Formulation of Fenofibrate is Suprabioavailable Compared to the Nanoparticle Tablet Formulation Under High-fat Fed Conditions

Roger K. Verbeeck, Sophie De Niet, Sonia Lebrun, Mickael Tremege, Tim W. Rennie, Monte Coffiner, Bruno Streel, Bernard Cahay

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2015)

Letter Immunology

Therapeutic Drug Monitoring in Tuberculosis: Practical Application for Physicians

Jan-Willem C. Alffenaar, Simon Tiberi, Roger K. Verbeeck, Scott K. Heysell, Martin P. Grobusch

CLINICAL INFECTIOUS DISEASES (2017)

Review Pharmacology & Pharmacy

Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring

Roger K. Verbeeck, Gunar Guenther, Dan Kibuule, Christian Hunter, Tim W. Rennie

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Editorial Material Chemistry, Medicinal

Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Enalapril

Roger K. Verbeeck, Isadore Kanfer, Raimar Lobenberg, Bertil Abrahamsson, Rodrigo Cristofoletti, D. W. Groot, Peter Langguth, James E. Polli, Alan Parr, Vinod P. Shah, Mehul Mehta, Jennifer B. Dressman

JOURNAL OF PHARMACEUTICAL SCIENCES (2017)

Article Pharmacology & Pharmacy

Monitoring of gentamicin serum concentrations in obstetrics and gynaecology patients in Namibia

Bonifasius S. Singu, Mwangana Mubita, Moses M. Thikukutu, Josef K. Mufenda, Shonag B. McKenzie, Roger K. Verbeeck

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2018)

Article Pharmacology & Pharmacy

Prediction of paraquat exposure and toxicity in clinically ill poisoned patients: a model based approach

Klintean Wunnapuk, Fahim Mohammed, Indika Gawarammana, Xin Liu, Roger K. Verbeeck, Nicholas A. Buckley, Michael S. Roberts, Flora T. Musuamba

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)

Article Respiratory System

Predictors of tuberculosis treatment success under the DOTS program in Namibia

Dan Kibuule, Roger K. Verbeeck, Ruswa Nunurai, Farai Mavhunga, Ette Ene, Brian Godman, Timothy W. Rennie

EXPERT REVIEW OF RESPIRATORY MEDICINE (2018)

Article Infectious Diseases

Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia

D. Kibuule, T. W. Rennie, N. Ruswa, F. Mavhunga, A. Thomas, R. Amutenya, M. R. Law, G. Gunther, E. Ette, B. Godman, R. K. Verbeeck

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2019)

Editorial Material Pharmacology & Pharmacy

Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients

Roger K. Verbeeck, Bonifasius S. Singu, Dan Kibuule

CLINICAL PHARMACOKINETICS (2019)

Article Medicine, Research & Experimental

Therapeutic drug monitoring of phenytoin and valproic acid in critically ill patients at Windhoek Central Hospital, Namibia

Bonifasius S. Singu, Helen Morrison, Lydia Irengeya, Roger K. Verbeeck

Summary: This retrospective study found that monitoring unbound plasma concentrations of phenytoin and valproic acid may provide a more accurate assessment of drug levels compared to total plasma drug concentrations. The majority of patients had unbound plasma concentrations of phenytoin or valproic acid outside the therapeutic range, highlighting the limitations of using total drug concentrations for dose optimization.

AFRICAN JOURNAL OF LABORATORY MEDICINE (2022)

Article Pediatrics

Plasma concentration and eGFR in preterm and term neonates receiving gentamicin or successive amikacin therapy

Bonifasius Siyuka Singu, Milka Ndapandula Ndeunyema, Ene I. Ette, Clarissa Hildegard Pieper, Roger Karel Verbeeck

Summary: This study aimed to determine the maximum and minimum plasma concentrations of gentamicin and amikacin in neonates, and assess their glomerular filtration rate (eGFR). The results showed that only a minority of neonates reached the therapeutic range of these drugs, but the majority were able to clear the drugs to below the toxicity threshold within 24 hours. Although amikacin led to a decrease in eGFR, most neonates were still able to clear the drug within the dosing interval.

BMC PEDIATRICS (2023)

Article Pharmacology & Pharmacy

Should Codeine Still Be Considered a WHO Essential Medicine?

Boni Singu, Roger K. Verbeeck

Summary: Codeine is widely used as an analgesic, antitussive, and antidiarrhoeal agent, but its analgesic effect varies greatly due to biotransformation to morphine by CYP2D6. Clinical trials have shown that codeine alone is the least effective in acute postoperative pain, and there is limited evidence to support its use as an antitussive. Additionally, codeine use can potentially lead to abuse and dependence, prompting the WHO to consider removing it from the list of essential medicines for adults.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2021)

Article Respiratory System

Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia

Dan Kibuule, Philomein Aiases, Nunurai Ruswa, Timothy William Rennie, Roger K. Verbeeck, Brian Godman, Mwangana Mubita

ERJ OPEN RESEARCH (2020)

Article Pharmacology & Pharmacy

Assessment of anticoagulation management in outpatients attending a warfarin clinic in Windhoek, Namibia

Lauren J. Jonkman, Marvelous P. Gwanyanya, Monika N. Kakololo, Roger K. Verbeeck, Bonifasius S. Singu

DRUGS & THERAPY PERSPECTIVES (2019)

Article Medical Laboratory Technology

Population Pharmacokinetic Analysis of Tacrolimus Early After Pediatric Liver Transplantation

Flora T. Musuamba, Vanessa Guy-Viterbo, Raymond Reding, Roger K. Verbeeck, Pierre Wallemacq

THERAPEUTIC DRUG MONITORING (2014)

Article Pharmacology & Pharmacy

Analysis of stabilization mechanisms in β-lactoglobulin-based amorphous solid dispersions by experimental and computational approaches

Xuezhi Zhuo, Vito Fodera, Per Larsson, Zarah Schaal, Christel A. S. Bergstrom, Korbinian Lobmann, Aleksei Kabedev

Summary: Our previous work demonstrated that beta-lactoglobulin-stabilized amorphous solid dispersion (ASD) loaded with 70 % indomethacin remains stable for over 12 months. We further investigated the stabilization mechanisms by testing five other drug molecules and using experimental techniques and molecular dynamics simulations. The results showed that steric confinement, hydrogen bonding, and the glass transition temperature of the drug molecule play important roles in stabilizing ASDs with high drug loadings.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Do the enantiomers of ketamine bind enantioselectively to human serum albumin?

Sebastian Schmidt, Ulrike Holzgrabe

Summary: The binding of drugs to plasma proteins, such as human serum albumin (HSA), is crucial for determining pharmacokinetic parameters. This study investigated the enantioselective binding of S- and R-ketamine to HSA. It was found that ketamine has weak affinity to HSA, with no significant differences in binding behavior between the individual enantiomers and the racemate. The aromatic ring and N-methyl group were identified as the most strongly involved structural moieties in the binding of ketamine to HSA.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases

Yuchen Zhao, Han Wang, Lin Jin, Ziwei Zhang, Lianghu Liu, Mengqi Zhou, Xianzheng Zhang, Lingling Zhang

Summary: Interleukins (ILs) are important for communication between immune cells and non-immune cells, but dysregulation of ILs expression is a characteristic of autoinflammatory diseases. Drugs targeting ILs have significant clinical benefits, but may also cause adverse reactions. Fusion protein technology, with its ability to enhance therapeutic efficacy, has been explored for developing anti-inflammatory drugs. This review discusses the efficacy of fusion protein drugs developed with ILs or their receptors in treating autoinflammatory diseases, highlighting the potential of this technology in future anti-inflammatory drug development.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

The use of polymorphic state modifiers in solid lipid microparticles: The role of structural modifications on drug release performance

Serena Bertoni, Elena Simone, Stefano Sangiorgi, Beatrice Albertini, Nadia Passerini

Summary: This study investigated the correlation between the structure and release properties of solid lipid microparticles (MPs) with different liquid additives. The additives accelerated the conversion of the unstable alpha-form of tristearin to the stable beta-polymorph and caused structural modifications in the MPs. The presence of additives prolonged the drug release in water and resulted in higher release profiles in biorelevant media. The findings suggest that the release behavior can be influenced by the polymorphism and supramolecular-level structural modification of lipid formulations containing crystal modifiers.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Altering distribution profile of palbociclib by its prodrugs

Juulia Jarvinen, Ahmed B. Montaser, Santosh Kumar Adla, Jukka Leppanen, Marko Lehtonen, Kati-Sisko Vellonen, Tuomo Laitinen, Aaro Jalkanen, William F. Elmquist, Juri Timonen, Kristiina M. Huttunen, Jarkko Rautio

Summary: This study attempted to alter the brain distribution pattern of Palbociclib by creating and assessing two novel prodrugs. Although the prodrug design did not significantly improve Palbociclib brain delivery, the study provides valuable insights for future prodrug development and drug delivery strategies targeting specific transporters.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Review Pharmacology & Pharmacy

The prescription design and key properties of nasal gel for CNS drug delivery: A review

Miao Wang, Xinyu Ma, Shiyu Zong, Yaqiong Su, Rui Su, Hong Zhang, Yang Liu, Chunliu Wang, Ye Li

Summary: This article discusses the potential and limitations of nasal administration in central nervous system drug delivery. Nasal gel viscosity can alleviate the impact of nasal mucociliary clearance on drug delivery, and materials such as gellan gum, chitosan, carbomer, cellulose, and poloxamer can be used to prepare nasal gels.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets

Bjarke Strom Larsen, Eric Kissi, Liebert Parreiras Nogueira, Natalja Genina, Ingunn Tho

Summary: This study investigates the influence of drug load and polymer molecular weight on the structure of 3D printed tablets. The results show that drug load and polymer molecular weight have a significant impact on the porosity and size of the tablets, while the effect of drug load on the total porosity of the tablets is minimal.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Ultrasound-guided periadventitial administration of rapamycin-fibrin glue attenuates neointimal hyperplasia in the rat carotid artery injury model

Zhentao Qiao, Fuhang Wang, Dongjian Han, Yuansong Zhuang, Qingjiao Jiang, Yi Zhang, Miaomiao Liu, Quanxu An, Zhiwei Wang, Deliang Shen

Summary: In this study, it was demonstrated that periadventitial delivery of rapamycin-fibrin glue (RPM-FG) can inhibit intimal hyperplasia (IH) in a rat carotid artery injury model without compromising re-endothelialization. This provides a promising direction for the future development of a safe, effective, and minimally invasive perivascular drug delivery method to treat vascular disease.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)

Article Pharmacology & Pharmacy

Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development

Neele Puhlmann, Rodrigo Vidaurre, Klaus Kuemmerer

Summary: Active pharmaceutical ingredients and their metabolites and transformation products are pollutants that can harm human and environmental health. Designing greener APIs is an effective strategy to address this issue. The drug discovery and development process can incorporate environmental parameters to achieve this design, and this process is highly flexible.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2024)